{"id":"https://openalex.org/W142171818","doi":null,"title":"[Characterizing the prescription of non-steroidal anti-inflammatory drugs among the elderly].","display_name":"[Characterizing the prescription of non-steroidal anti-inflammatory drugs among the elderly].","publication_year":2007,"publication_date":"2007-01-01","ids":{"openalex":"https://openalex.org/W142171818","mag":"142171818","pmid":"https://pubmed.ncbi.nlm.nih.gov/17388090"},"language":"es","primary_location":{"id":"pmid:17388090","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17388090","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gaceta medica de Mexico","raw_type":"English Abstract"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034947660","display_name":"Alma Luisa Lagunes-Espinosa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I164915025","display_name":"Mexican Social Security Institute","ror":"https://ror.org/03xddgg98","country_code":"MX","type":"government","lineage":["https://openalex.org/I164915025"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Alma Luisa Lagunes-Espinosa","raw_affiliation_strings":["Unidad de Medicina Familiar, IMSS, Estado de M\u00e9xico, M\u00e9xico. al5897122@prodigy.net.mx"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unidad de Medicina Familiar, IMSS, Estado de M\u00e9xico, M\u00e9xico. al5897122@prodigy.net.mx","institution_ids":["https://openalex.org/I164915025"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000407917","display_name":"Mar\u00eda Luisa Peralta\u2010Pedrero","orcid":"https://orcid.org/0000-0003-0301-1955","observed_orcids":["https://orcid.org/0000-0003-0301-1955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Luisa Peralta-Pedrero","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043463772","display_name":"Jos\u00e9 Raymundo Rodr\u00edguez\u2010Moctezuma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raymundo Rodr\u00edguez-Moctezuma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008570163","display_name":"Juan Manuel L\u00f3pez-Carmona","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan Manuel L\u00f3pez-Carmona","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058086353","display_name":"Emilia Ibarra-Vicens","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emilia Ibarra-Vicens","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072500434","display_name":"Agles Cruz-Avelar","orcid":"https://orcid.org/0000-0002-5232-6470","observed_orcids":["https://orcid.org/0000-0002-5232-6470"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Agles Cruz-Avelar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5066659016","display_name":"Catarina Mungu\u00eda-Miranda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Catarina Murgu\u00eda-Miranda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.6213,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.75574388,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"143","issue":"1","first_page":"5","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9959999918937683},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.7620000243186951},{"id":"https://openalex.org/keywords/prescribing-patterns","display_name":"prescribing patterns","score":0.7960000038146973},{"id":"https://openalex.org/keywords/aspirin","display_name":"aspirin","score":0.8960000276565552},{"id":"https://openalex.org/keywords/naproxen","display_name":"naproxen","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-disease-interactions","display_name":"drug-disease interactions","score":0.9900000095367432},{"id":"https://openalex.org/keywords/gastroprotective-effect","display_name":"gastroprotection","score":0.7570000290870667},{"id":"https://openalex.org/keywords/cardiovascular-disease-prevention","display_name":"cardiovascular disease prevention","score":0.800000011920929},{"id":"https://openalex.org/keywords/pain-management","display_name":"pain management","score":0.9190000295639038},{"id":"https://openalex.org/keywords/primary-care","display_name":"primary care","score":0.5870000123977661},{"id":"https://openalex.org/keywords/treatment-duration","display_name":"treatment duration","score":0.3720000088214874}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5228386521339417},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.4136480689048767},{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.3846067190170288},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.22347784042358398}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:17388090","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17388090","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Gaceta medica de Mexico","raw_type":"English Abstract"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W109693009","https://openalex.org/W131464615","https://openalex.org/W1577440990","https://openalex.org/W1632695432","https://openalex.org/W1847168837","https://openalex.org/W1992746042","https://openalex.org/W1994835315","https://openalex.org/W1995739533","https://openalex.org/W1998785842","https://openalex.org/W2005930138","https://openalex.org/W2013480805","https://openalex.org/W2020648326","https://openalex.org/W2037109573","https://openalex.org/W2040595591","https://openalex.org/W2054825239","https://openalex.org/W2074748651","https://openalex.org/W2082862318","https://openalex.org/W2083732694","https://openalex.org/W2112554263","https://openalex.org/W2128063214","https://openalex.org/W2129873159","https://openalex.org/W2158372704","https://openalex.org/W2158388065","https://openalex.org/W2160950772","https://openalex.org/W2189592079","https://openalex.org/W2399597948"],"related_works":["https://openalex.org/W4252672057","https://openalex.org/W4235626270","https://openalex.org/W2950360778","https://openalex.org/W1781208039","https://openalex.org/W7104183900","https://openalex.org/W3092332739","https://openalex.org/W2752198654","https://openalex.org/W2321543445","https://openalex.org/W1527009456","https://openalex.org/W3011486454"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Determine":[1],"prescription":[2,65,198,221],"characteristics":[3],"of":[4,25,81,157],"non-steroidal":[5],"anti-inflammatory":[6,147],"drugs":[7],"among":[8,203],"the":[9,109],"elderly":[10],"attending":[11],"primary":[12],"medical":[13],"care.":[14],"MATERIAL":[15],"AND":[16],"METHODS:":[17],"Setting,":[18],"Family":[19],"Health":[20],"Unit":[21],"52,":[22],"Mexican":[23],"Institute":[24],"Social":[26],"Security.":[27],"DESIGN:":[28],"Prospective,":[29],"cross-sectional,":[30],"descriptive,":[31],"with":[32,208],"randomized":[33],"sampling.":[34],"PARTICIPANTS:":[35],"400":[36],"patients;":[37],"aged":[38],"60":[39],"and":[40,43,58,60,64,99,123,153,185,232],"older,":[41],"male":[42],"female,":[44],"without":[45,49,243],"cognitive":[46],"impairment.":[47],"Those":[48],"clinical":[50,62],"records":[51],"were":[52,66,70],"excluded.":[53],"Every":[54],"patient":[55],"was":[56,83,114,164,199],"interviewed":[57],"examined":[59],"their":[61,230],"record":[63],"assesed.":[67],"RESULTS:":[68],"NSAIDs":[69,82,206,220],"prescribed":[71,84,115],"in":[72,85,93,102,116,125,136,142,155,178,190],"312":[73],"patients":[74,169,204],"(78%":[75],"95%":[76,88,96,105,120,129,139,171,182,193],"CI":[77,89,97,106,121,145,151,160,172,183,194,214],"74-82),":[78],"one":[79],"type":[80],"188":[86],"(60%":[87],"55-65),":[90],"two":[91],"types":[92,101],"117":[94],"(38%":[95],"33-43)":[98],"three":[100],"7":[103],"(2%":[104],"0.0-4).":[107],"Of":[108],"443":[110],"prescriptions,":[111],"Acetylsalicylic":[112],"acid":[113],"200":[117],"cases":[118,148,158,180],"(45%":[119],"40-50)":[122],"Naproxen":[124],"100":[126],"(23%":[127],"IC":[128],"19-26).":[130],"Reasons":[131],"for":[132,167],"prescribing":[133],"included":[134],"cardiovascularprophylaxis":[135],"46%":[137],"(IC":[138],"7-13)pain":[140],"management":[141],"40%":[143],"(95%":[144,150,159,213],"31-49),":[146],"4%":[149],"2-6),":[152],"non-specified":[154],"10%":[156],"7-13).":[161],"Treatment":[162],"duration":[163],"not":[165,200,228,237],"specified":[166],"253":[168],"(81%":[170],"77-85).":[173],"We":[174],"noted":[175],"drug-drug":[176],"interaction":[177,189],"228":[179],"(73%":[181],"67-77)":[184],"a":[186],"potential":[187],"drug-disease":[188,247],"247":[191],"(79%":[192],"77-81).":[195],"The":[196],"gastro-esophageal":[197,233],"more":[201],"frequent":[202],"taking":[205,244],"compared":[207],"non-users":[209],"OR":[210],"=":[211,217],"1":[212],"0.53-1.75;":[215],"p":[216],"0.89).":[218],"CONCLUSIONS:":[219],"prevalence":[222],"is":[223,235],"high:":[224],"although":[225],"diagnoses":[226],"do":[227],"justify":[229],"use":[231],"protection":[234],"often":[236],"sufficient.":[238],"Prostaglandins":[239],"inhibitors":[240],"are":[241],"favored":[242],"into":[245],"account":[246],"interaction.":[248]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}